Compugen Stock

Compugen Retained Earnings

Delisted·Jun 15, 2026

The Retained Earnings of Compugen (CGEN) as of Aug 3, 2026 is -453.42 M USD. In the previous year, Retained Earnings was -488.76 M USD — a change of -7.23% (higher).

Retained Earnings

-453.42 MUSD

YoY

-7.23%

Last updated:

Retained Earnings of Compugen is 2026 -453.42 M USD. Retained Earnings of Compugen was 2025 -488.76 M USD. It decreases by -7.23% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Retained Earnings of Compugen is -453.42 M USD in 2026.

Retained Earnings of Compugen changed from -488.76 M USD to -453.42 M USD, representing a -7.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Compugen since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Compugen historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Compugen

All Key Metrics — Compugen